Bitcoin ($BTC) drops below $107,500 as September starts with volatility and bearish sentiment, yet crypto investors are cautiously eyeing potential recovery.Bitcoin ($BTC) drops below $107,500 as September starts with volatility and bearish sentiment, yet crypto investors are cautiously eyeing potential recovery.

Bitcoin Drops Below $107,500 as September Kicks Off with Heightened Volatility

bitcoin31

Bitcoin ($BTC) has started September 2025 with a significant dip. As per the latest market data, Bitcoin ($BTC) has dropped below $107,500, signifying a very bearish investor sentiment. In this respect, the decline in the market momentum raises the risk of further downside in the near term. However, despite the heightened volatility at the start of the month, there is still a possibility for a substantial recovery.

September Begins with Massive $BTC Sell-Offs as Price Plunges to $107,378

At the moment, based on the price chart, Bitcoin ($BTC) is changing hands below the $107,500 mark. Particularly, the price level of up to $107,378.96 takes into account a 1.32% decrease over the past twenty-four hours. In addition to this, the market capitalization of the flagship cryptocurrency has also slumped to $2.13T, denoting a 1.29% decrease. At the same time, the 7-day performance of Bitcoin ($BTC) presents a 4.76% dip.

Bitcoin Price Chart

In the broader context, on Labor Day, Bitcoin ($BTC) is facing the risk of a substantial price crash. Additionally, the traders are extremely cautious as it seems very difficult for Bitcoin to maintain its price level. Keeping this in view, the $BTC holders are engaging in selling activity amid the growing pressure.

Bitcoin ($BTC) Faces Liquidity Strain Amid Bearish Sentiment

There are still some long-term market participants who expect the U.S. President Donald Trump to begin interest rate cutting by this month’s end or October’s start. Even then, the respective hopes are not enough to enhance the short-term sentiment among investors. In this case, the increased sell-offs are impacting the $BTC liquidity, elevating the apprehensions of additional downturn.

In line with the exclusive market statistics, the overall bearish sentiment around Bitcoin ($BTC) has also influenced its market dominance which has dipped to 57.4%. Thus, the crypto asset, which is deemed as digital gold, is struggling to hold its position above the $107K spot. Nonetheless, the current plunge might offer a crucial buying opportunity as, irrespective of the initial dip in September 2025, Bitcoin could experience a notable recovery in the near future.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$95,482.46
$95,482.46$95,482.46
-1.33%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26